doi: 10.1126/science.abf0529 99 TanRWenKZhaoTGuoHHanXWangJet al
Agents such as semaglutide and tirzepatide improve metabolic parameters reliably without worsening baseline inflammatory disease activity ( Signals for disease modification Evidence for true disease modification remains low-certainty and hypothesis-generating, with recent observational signals serving as a foundation for potential disease modification rather than established therapeutic benefit ( A critical real-world evidence (RWE) appraisal of these cohorts reveals significant limitations
Patients with pre-existing joint conditions, obesity-related joint loading, or older age may be at greater baseline risk of musculoskeletal symptoms during treatment
AbbVies Rinvoq (Upadacitinib) reached $1.72 billion, up 57% YoYlikely to join the TOP10 soon
As a general rule, IM is favored when the goal is rapid correction of a clinical deficiency, when the patient has difficulty absorbing B12 through oral or sublingual routes, or when a provider wants predictable peak serum levels
For those looking into weight loss management, it is incredibly important to be aware of the differences between the most popular options to ensure that you come to an appropriate choice for your situation
)
